| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | -64.7% |
| Cost of Revenue | $557K | -31.3% |
| Gross Profit | $461K | -77.8% |
| R&D Expense | $4.6M | -11.8% |
| SG&A Expense | $6.2M | +55.0% |
| Operating Income | -$10.7M | +23.7% |
| Pre-tax Income | -$10.4M | +6.0% |
| Net Income | -$10.4M | +6.0% |
| EPS (Basic) | -$6.16 | +58.6% |
| EPS (Diluted) | -$6.16 | +59.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.1M | +15.1% |
| Accounts Receivable | $178K | -9.2% |
| Inventory | $825K | +64.3% |
| Current Assets | $5.7M | +18.4% |
| Total Assets | $9.5M | +1.0% |
| Current Liabilities | $3.7M | +88.3% |
| Total Liabilities | $6.6M | +19.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.6M | +0.8% |
| Capital Expenditures | $185K | -73.2% |
| Investing Cash Flow | $913K | +570.6% |
| Financing Cash Flow | $8.2M | -9.8% |
| Free Cash Flow | -$8.8M | +6.2% |
| $2.9M |
| -24.8% |